What is true about statin-associated liver enzyme elevations?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

What is true about statin-associated liver enzyme elevations?

Statin-associated liver enzyme elevations are typically mild and reversible, and the main safety signal to watch for is a rise that exceeds three times the upper limit of normal. This threshold is what triggers further evaluation for potential hepatotoxicity, because larger, persistent elevations are the findings most concerning for liver injury and may necessitate stopping the medication or adjusting management. In contrast, small increases are common and often transient, and do not by themselves mean the statin must be discontinued. So the best statement reflects that a transaminase rise above 3× ULN is the signal to reassess liver injury risk. Elevations are not common enough to require discontinuation in most patients, they can occur even in people without liver disease, and LFTs can rise with statin therapy (though typically modestly).

Statin-associated liver enzyme elevations are typically mild and reversible, and the main safety signal to watch for is a rise that exceeds three times the upper limit of normal. This threshold is what triggers further evaluation for potential hepatotoxicity, because larger, persistent elevations are the findings most concerning for liver injury and may necessitate stopping the medication or adjusting management. In contrast, small increases are common and often transient, and do not by themselves mean the statin must be discontinued.

So the best statement reflects that a transaminase rise above 3× ULN is the signal to reassess liver injury risk. Elevations are not common enough to require discontinuation in most patients, they can occur even in people without liver disease, and LFTs can rise with statin therapy (though typically modestly).

More practice questions